Amneal Pharmaceuticals LLC has launched budesonide capsules, 3 mg, an AB-rated equivalent to Entocort® EC. Budesonide is the first product launch of the new year for Amneal Pharmaceuticals. In 2017, the company received 45 ANDA approvals (39 final and 6 tentative) and launched 35 product families—nine of these by its injectables subsidiary Amneal Biosciences.